comparemela.com
Home
Live Updates
NephroDI Therapeutics Enters Agreement to Develop a First-in-Class Treatment for a Genetic, Rare Disease of the Kidneys : comparemela.com
NephroDI Therapeutics Enters Agreement to Develop a First-in-Class Treatment for a Genetic, Rare Disease of the Kidneys
SEATTLE--(BUSINESS WIRE)--Jun 22, 2023--
Related Keywords
United States ,
Seattle ,
Washington ,
Josh Knackert ,
Rachael Hagan ,
Nephrodi Therapeutics Inc ,
Mcquade Center ,
Strategic Research ,
Nephrogenic Diabetes Insipidus ,
Business Wire ,
Business ,
comparemela.com © 2020. All Rights Reserved.